计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| A127698-5mg |
5mg |
现货 ![]() |
| |
| A127698-25mg |
25mg |
现货 ![]() |
| |
| A127698-100mg |
100mg |
期货 ![]() |
|
| 英文别名 | AZD 1208 [WHO-DD] | Q27074698 | FT-0633869 | J-013789 | HY-15604 | S98NFM1378 | SW219766-1 | 1204144-28-4 | AZ-1208 | (R,Z)-5-((2-(3-Aminopiperidin-1-yl)biphenyl-3-yl)methylene)thiazolidine-2,4-dione | AZD1208 | AZD-1208 | NSC776066 | NSC-776066 | (R,Z)-5 |
|---|---|
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | AZD1208 |
| 生化机理 | 高效泛Pim激酶抑制剂(Pim-1、3和2的IC50值分别为0.4、1.9和5.0 nM)。与其他激酶相比,对Pim激酶的亲和力高> 43倍。在体外诱导AML细胞系中的细胞周期停滞和凋亡,并在体内抑制肿瘤异种移植物的生长。化学增敏剂。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | Pim-1 原癌基因抑制剂;丝氨酸/苏氨酸激酶;Pim-2 原癌基因抑制剂;丝氨酸/苏氨酸激酶;Pim-3 原癌基因抑制剂;丝氨酸/苏氨酸激酶 |
| 产品介绍 |
AZD1208是口服活性的PIM高选择性抑制剂,对Pim1, Pim2, 和 Pim3的IC50分别为5 nM, 25 nM 和 16 nM。 AZD1208 is a potent, and orally available Pim kinase inhibitor with IC50 of 0.4 nM, 5 nM, and 1.9 nM for Pim1, Pim2, and Pim3 in cell-free assays, respectively. |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | (5Z)-5-[[2-[(3R)-3-aminopiperidin-1-yl]-3-phenylphenyl]methylidene]-1,3-thiazolidine-2,4-dione |
| INCHI | 1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19-15(12-18-20(25)23-21(26)27-18)8-4-10-17(19)14-6-2-1-3-7-14/h1-4,6-8,10,12,16H,5,9,11,13,22H2,(H,23,25,26)/b18-12-/t16-/m1/s1 |
| InChi Key | MCUJKPPARUPFJM-UWCCDQBKSA-N |
| Smiles | C1CC(CN(C1)C2=C(C=CC=C2C3=CC=CC=C3)C=C4C(=O)NC(=O)S4)N |
| Isomeric SMILES | C1C[C@H](CN(C1)C2=C(C=CC=C2C3=CC=CC=C3)/C=C\4/C(=O)NC(=O)S4)N |
| 分子量 | 379.48 |
| Reaxy-Rn | 30682637 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=30682637&ln= |
| 溶解性 | 溶于DMSO, 最高浓度 (mg/mL): 7.59, 最高浓度(mM): 20 温和加热 |
|---|---|
| 分子量 | 379.500 g/mol |
| XLogP3 | 3.600 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 379.135 Da |
| 单同位素质量Monoisotopic Mass | 379.135 Da |
| 拓扑极表面积Topological Polar Surface Area | 101.000 Ų |
| 重原子数Heavy Atom Count | 27 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 602.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 1 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Keeton EK, McEachern K, Dillman KS, Palakurthi S, Cao Y, Grondine MR, Kaur S, Wang S, Chen Y, Wu A et al.. (2014) AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.. Blood, 123 (6): (905-13). [PMID:24363397] |
| 2. Burger MT, Han W, Lan J, Nishiguchi G, Bellamacina C, Lindval M, Atallah G, Ding Y, Mathur M, McBride C et al.. (2013) Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors.. ACS Med Chem Lett, 4 (12): (1193-7). [PMID:24900629] |